Cel-Sci Corporation, a US late-stage oncology company and a developer of vaccines and drugs for the treatment of infectious diseases, has appointed Todd Burkhart as vice president of manufacturing/facilities and commercial operations for its manufacturing facility.
Burkhart has more than 30 years" experience in the manufacture and process development of biologicals, medical devices and other Active Pharmaceutical Ingredients (APIs). Prior to joining Cel-Sci, Burkhart has been responsible for all aspects of GMP manufacturing and operations. In addition he has extensive experience in the design of manufacturing facilities meeting FDA GMP requirements. He has also been involved in building and/or running a number of major pharmaceutical facilities at companies such as Cephalon, Human Genome Sciences and Univax Biologics.